Heyholder
‹ Back to the disclosure you were reading

PROTEINA CO.,LTD. KRW 29.2 billion convertible bond issuance, conversion price KRW 48,061

PROTEINA CO.,LTD.· Material Event Report

AI summary · Not investment advice

Issues KRW 29.2 billion in private convertible bonds at a conversion price of KRW 48,061, with payment on Nov 12, 2026.

Total face value

KRW 29.2 billion

Key facts

Bond type
Series 1 registered-free unsecured private convertible bond
Capital expenditure
KRW 20.8 billion
Working capital
KRW 8.4 billion
Coupon rate
0.0%
Yield to maturity
1.0%
Maturity date
Nov 12, 2031
Conversion price per share
KRW 48,061
Convertible shares
607,561 shares
% of total shares
5.19%
Conversion period
Nov 12, 2027 – Oct 12, 2031
Call option limit
Up to KRW 5,840,000,000 (Call Option 20%)
First put date
Feb 12, 2029
Payment date
Nov 12, 2026
Board resolution date
Nov 4, 2026

Commentary

AI commentary · Not investment advice

What happened

Proteina decided to issue KRW 29.2 billion of convertible bonds (bonds that can later be turned into shares). This is the 1st series, a privately placed, unsecured bearer bond. KRW 20.8 billion is for facilities and KRW 8.4 billion for operations. Timefolio Biohealthcare New Technology Investment Partnership No. 2 takes KRW 6.0 billion of the bonds.

In the company's terms

The bonds pay a coupon rate of 0.0%. At maturity, a 1.0% interest rate applies. The maturity date is 2031.11.12.

What changes for shareholders

The conversion price is KRW 48,061 per share. Full conversion would create 607,561 new shares, which is 5.19% of total shares. Holders can convert from 2027.11.12 to 2031.10.12. The company has a call option (a right to buy back bonds) of up to KRW 5,840,000,000, set at 20%. Holders have a put option (a right to demand early repayment), first exercisable on 2029.02.12.

Earlier Material Event Report filings from this company

Filings of the same type
FiledTitleKey figure · Note
26.11.04Material Event Report151,886 shares · Shares outstanding before offering: 11,105,148
Show Korean comments

Comments

No comments yet

Comments from shareholders will appear here.